At the 2025 UCSF-UCLA PSMA Conference, Michael Hofman presents the PRIMARY score for PSMA PET in prostate cancer diagnosis. He explains how PSMA PET complements MRI, preventing missed clinically significant cancers (17%) and details the five-point scoring system where 1-2 suggests benign and 3-5 indicates increasing cancer likelihood. Dr. Hofman discusses the PRIMARY2 trial testing whether PSMA…
Explore the specifications of the Fibion Vitals, a cutting-edge wearable device designed for comprehensive health monitoring. This episode provides a detaile…
Uncover advanced sleep and activity insights with Fibion Sleep. Offering 24-hour data collection, long-lasting battery, and flexible algorithmic analysis for comprehensive research
Ashish Kamat is joined by Alexandre Zlotta to discuss the evolution of AI in bladder cancer management. Dr. Zlotta highlights work developing an AI model…
CDC is America’s first line of defense against global health threats.
Knowing heightened risks can help women be proactive about health, researcher said
The MedCity News Audience Survey gives readers an opportunity to share their thoughts on the leading online news source for the business of innovation in…
Isaacs and Bellini cover 3 of the most pivotal trial results from the 85th annual American Diabetes Association conference in part 1 of this 2-part…
President Trump said he was likely to impose tariffs on pharmaceuticals as soon as the end of the month, starting with a “low tariff”
Some people with obesity are resistant to the adverse cardiometabolic effects of excess adiposity and are considered to have “metabolically healthy obesity.” Petersen et al. evaluated…
